Proliferation, DNA ploidy, p53 overexpression and nuclear DNA fragmentation in six equine melanocytic tumours

Citation
S. Roels et al., Proliferation, DNA ploidy, p53 overexpression and nuclear DNA fragmentation in six equine melanocytic tumours, J VET MED A, 47(7), 2000, pp. 439-448
Citations number
37
Categorie Soggetti
Veterinary Medicine/Animal Health
Journal title
JOURNAL OF VETERINARY MEDICINE SERIES A-PHYSIOLOGY PATHOLOGY CLINICAL MEDICINE
ISSN journal
0931184X → ACNP
Volume
47
Issue
7
Year of publication
2000
Pages
439 - 448
Database
ISI
SICI code
0931-184X(200009)47:7<439:PDPPOA>2.0.ZU;2-E
Abstract
Melanocytic tumours are a well-known clinical and pathological entity in ho rses, but further phenotypic characterization of these rumours is lacking. Six melanocytic tumours from five horses (two metastatic and four benign) w ere examined by Ki67, PCNA and p53 immunostaining, DNA nick end labelling ( Tunel) and Feulgen staining. The stainings were evaluated using quantitativ e image analysis. The resulting parameters of growth fraction (Ki67), S-pha se index (PCNA), p53 index, apoptotic index, DNA index, nuclear diameter, p loidy balance, proliferation index (Feulgen) and hyperploidy were analysed. The metastatic melanomas showed overexpression of p53 in a large portion o f the cells. Apoptosis was also found in the metastatic melanomas. No diffe rences were found in growth fraction, S-phase index (PCNA) nor in DNA confi guration between the metastatic and the benign tumours. No immunohistochemi cal evidence of mutant p53 could be found in the rumours. In conclusion, me lanocytic rumours in horses seem to have different phenotypic characteristi cs in comparison with melanocytic rumours in dogs, cats and humans, especia lly with respect to proliferative activity of the benign tumours. Therefore , markers put forward in these other species for predicting the clinical be haviour of the melanomas seem to be of no value in the horse. Moreover, qua ntitative DNA changes or p53 mutations do not seem to be involved in tumour ogenesis in these cases.